acetonitrile has been researched along with sorafenib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Escudero-Ortiz, V; Pérez-Ruixo, JJ; Valenzuela, B | 1 |
| Akasaka, K; Hisamichi, K; Kondo, Y; Maejima, T; Maekawa, M; Mano, N; Matsuura, M; Mori, M; Okawa, H; Shimada, M; Shimosegawa, T; Suzuki, H; Tsuchiya, M; Yanagi, T | 1 |
2 other study(ies) available for acetonitrile and sorafenib
| Article | Year |
|---|---|
Development and validation of a high-performance liquid chromatography ultraviolet method for lapatinib quantification in human plasma.
Topics: Acetonitriles; Administration, Oral; Antineoplastic Agents; Calibration; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Lapatinib; Limit of Detection; Niacinamide; Phenylurea Compounds; Quinazolines; Sorafenib; Spectrophotometry, Ultraviolet | 2013 |
A quantitative HPLC-UV method for determination of serum sorafenib and sorafenib N-oxide and its application in hepatocarcinoma patients.
Topics: Acetonitriles; Carcinoma, Hepatocellular; Chromatography, High Pressure Liquid; Drug Stability; Humans; Ions; Liver Neoplasms; Mass Spectrometry; Niacinamide; Oxides; Phenylurea Compounds; Reference Standards; Solubility; Solutions; Sorafenib; Ultraviolet Rays | 2014 |